U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
SETRUSUMAB
FPW3780T3E
Investigational
General
Names
7
Classification
4
Identifiers
5
Subunits
4
Related Substances
1
SETRUSUMAB
FPW3780T3E
Investigational
General
Approval Year
Unknown
139,594
Names
7
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
SETRUSUMAB
Official Name
English
BPS804
Code
English
MOR05813
Code
English
setrusumab [INN]
Common Name
English
BPS-804
Code
English
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Classification
4
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Pharmacologic Substance
Pharmacologic Substance
[C1909]
Agent Affecting Musculoskeletal System
NCI_THESAURUS
C78281
Designated
ORPHAN DRUG
Designated
Treatment of osteogenesis imperfecta.
FDA ORPHAN DRUG
508615
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Positive
EU ORPHAN DRUG
Positive
Treatment of osteogenesis imperfecta
EU-Orphan Drug
EU/3/16/1686
Showing 1 to 4 of 4 entries
Previous
1
Next
Identifiers
5
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
NCI_THESAURUS
C152352
PRIMARY
CAS
1847394-95-9
PRIMARY
INN
10539
PRIMARY
DRUG BANK
DB14778
PRIMARY
FDA UNII
FPW3780T3E
PRIMARY
Showing 1 to 5 of 5 entries
Previous
1
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
FPW3780T3E
SETRUSUMAB